Analyst consensus rating
Bright Minds Biosciences Analyst Rating: Strong Buy
Direct answer
Bright Minds Biosciences's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $167.18.
Forecast evidence checked September 24, 2026.
Get free Bright Minds Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $53.51
- Average price target
- $167.18
- High price target
- $217.65
- Low price target
- $141.68
- Low target gap
- +164.8%
- Target upside
- +212.4%
- High target gap
- +306.7%
- Target range width
- 142%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 24, 2026
- Valid through
- October 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bright Minds Biosciences?
Bright Minds Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $167.18.
How far are Bright Minds Biosciences's low and high targets from the recorded price?
The low target implies +164.8%, while the high target implies +306.7%.
How many analysts are included in Bright Minds Biosciences's consensus?
The verified consensus includes 3 analysts.
How is Bright Minds Biosciences's target upside or downside calculated?
The average target of $167.18 is divided by the recorded price of $53.51, then one is subtracted to produce +212.4%. This does not guarantee a future return.
When was Bright Minds Biosciences's analyst forecast verified?
The data was verified on 2026-09-24. The dataset is valid through 2026-10-01.